Authors: Ducloux, D Bresson-Vautrin, C Chalopin, JM

Citation: D. Ducloux et al., Use of pentoxifylline in membranous nephropathy, LANCET, 357(9269), 2001, pp. 1672-1673

Authors: Ducloux, D Carron, PL Racadot, E Rebibou, JM Bresson-Vautrin, C Hillier, YS Chalopin, JM

Citation: D. Ducloux et al., T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies, TRANSPLAN I, 12(4), 1999, pp. 250-253

Authors: Ducloux, D Motte, G Vautrin, P Bresson-Vautrin, C Rebibou, JM Chalopin, JM

Citation: D. Ducloux et al., Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus, NEPH DIAL T, 14(5), 1999, pp. 1244-1246

Authors: Ducloux, D Heuze-Lecornu, L Gibey, R Bresson-Vautrin, C Vautrin, P Chalopin, JM

Citation: D. Ducloux et al., Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysispatients, NEPH DIAL T, 14(3), 1999, pp. 728-731

Authors: Ducloux, D Pellet, E Fournier, V Rebibou, JM Bresson-Vautrin, C Racadot, E Fellmann, D Chalopin, JM

Citation: D. Ducloux et al., Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients, TRANSPLANT, 67(1), 1999, pp. 90-93

Authors: Ducloux, D Bresson-Vautrin, C Chalopin, JM

Citation: D. Ducloux et al., Ocular venous occlusion and hyperhomocysteinemia, ANN INT MED, 131(7), 1999, pp. 548-549